Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives

Authors
Ferraccioli, GF Di Poi, E Damato, R
Citation
Gf. Ferraccioli et al., Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives, CLIN EXP RH, 18(4), 2000, pp. S58-S60
Citations number
18
Categorie Soggetti
Rheumatology,"da verificare
Journal title
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
ISSN journal
0392856X → ACNP
Volume
18
Issue
4
Year of publication
2000
Supplement
20
Pages
S58 - S60
Database
ISI
SICI code
0392-856X(200007/08)18:4<S58:SSTATP>2.0.ZU;2-B
Abstract
The therapeutic approach to polymyalgia rheumatica (PMR) and giant cell art eritis (GCA) remains mainly based on corticosteroids. A few studies in PMR suggest a steroid-sparing effect with methotrexate in a subset of patients. No real alternative to steroids exists in GCA. Given the high chance of lo ng-term treatment with corticosteroids in both diseases, randomized control led trials with new immunosuppressive steroid-sparing drags are eagerly awa ited.